21309-Peritoneal Cancer-NA-150

Peritoneal Cancer

UPIFITAMAB RILSODOTIN (XMT-1536)AN OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND EXPANSION STUDY OF UPIFITAMAB RILSODOTIN IN COMBINATION WITH CARBOPLATIN IN PARTICIPANTS WITH HIGH-GRADE SEROUS OVARIAN CANCER: A MODULAR STUDY RELATED TO UPGRADE UMBRELLA MASTER STUDY (UPGRADE-A) (MER-XMT-1536-2A)

  • Details

ClinicalTrials.gov ID: NCT04907968
Diagnosis Type: NA
USOR Number:

  • Address

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

Search by practice name, trial titles, indicators and specific disease types.